Free Trial
OTCMKTS:GTHP

Guided Therapeutics (GTHP) Stock Price, News & Analysis

Guided Therapeutics logo
$0.10 +0.00 (+4.17%)
As of 03:21 PM Eastern

About Guided Therapeutics Stock (OTCMKTS:GTHP)

Key Stats

Today's Range
$0.10
$0.10
50-Day Range
$0.08
$0.11
52-Week Range
$0.06
$0.23
Volume
1,919 shs
Average Volume
16,200 shs
Market Capitalization
$7.89 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorporated in 1992 and is based in Norcross, Georgia.

Receive GTHP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Guided Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

GTHP Stock News Headlines

This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.
Guided Therapeutics Inc (GTHP)
Guided Therapeutics Inc
See More Headlines

GTHP Stock Analysis - Frequently Asked Questions

Guided Therapeutics' stock was trading at $0.15 at the beginning of the year. Since then, GTHP shares have decreased by 33.3% and is now trading at $0.10.
View the best growth stocks for 2025 here
.

Guided Therapeutics, Inc. (OTCMKTS:GTHP) issued its earnings results on Monday, March, 31st. The company reported ($0.02) earnings per share for the quarter.

Shares of GTHP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Guided Therapeutics investors own include Cornerstone Strategic Value Fund (CLM), Intel (INTC), Beam Therapeutics (BEAM), ChargePoint (CHPT), CSX (CSX), Warner Bros. Discovery (DISCA) and Enbridge (ENB).

Company Calendar

Last Earnings
3/31/2025
Today
5/08/2025
Next Earnings (Estimated)
5/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Electromedical equipment
Sub-Industry
Medical Equipment
Current Symbol
OTCMKTS:GTHP
Employees
5
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-3,490,000.00
Pretax Margin
-5,660.53%

Debt

Sales & Book Value

Annual Sales
$100,000.00
Price / Cash Flow
N/A
Book Value
($0.13) per share
Price / Book
-0.74

Miscellaneous

Free Float
21,673,000
Market Cap
$7.58 million
Optionable
Not Optionable
Beta
0.21
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (OTCMKTS:GTHP) was last updated on 5/8/2025 by MarketBeat.com Staff
From Our Partners